12-52790289-C-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_057088.3(KRT3):c.1640G>A(p.Gly547Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000187 in 1,559,680 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_057088.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KRT3 | NM_057088.3 | c.1640G>A | p.Gly547Asp | missense_variant | 9/9 | ENST00000417996.2 | NP_476429.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KRT3 | ENST00000417996.2 | c.1640G>A | p.Gly547Asp | missense_variant | 9/9 | 1 | NM_057088.3 | ENSP00000413479.2 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000801 AC: 13AN: 162378Hom.: 0 AF XY: 0.0000806 AC XY: 7AN XY: 86840
GnomAD4 exome AF: 0.000195 AC: 275AN: 1407560Hom.: 0 Cov.: 32 AF XY: 0.000194 AC XY: 135AN XY: 694970
GnomAD4 genome AF: 0.000105 AC: 16AN: 152120Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74310
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2021 | The c.1640G>A (p.G547D) alteration is located in exon 9 (coding exon 9) of the KRT3 gene. This alteration results from a G to A substitution at nucleotide position 1640, causing the glycine (G) at amino acid position 547 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at